Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1215.4000 22.40 (1.88%)
NSE Jan 02, 2026 15:31 PM
Volume: 516.1K
 

1215.40
1.88%
BOB Capital Markets Ltd.
Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E
Number of FII/FPI investors decreased from 728 to 700 in Sep 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended